インターベンショナルカーディオロジーデバイス市場規模、成長と動向分析レポート 2025-2033年

インターベンショナルカーディオロジーデバイス市場 – 製品（冠動脈ステント、PTCAバルーンカテーテル、血管内画像カテーテルおよび圧ガイドワイヤー、アクセサリデバイス）、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年

世界のインターベンショナルカーディオロジーデバイス市場規模は、2024年に105億7,000万米ドルと推定され、2025年から2033年にかけて7.25%のCAGRで成長し、2033年には197億5,000万米ドルに達すると予測されています。市場の成長は、心血管疾患の罹患率の上昇、低侵襲手術の需要増加、薬剤溶出ステントや生体吸収性血管スキャフォールドなどの技術進歩によって推進されています。

高齢者人口の増加、医療費の増加、そして新興市場における心臓治療へのアクセス向上も、市場拡大に貢献しています。製品イノベーション、そしてカテーテルを用いた介入におけるAIと画像技術の統合も、需要をさらに押し上げています。心血管疾患の罹患率の上昇は、市場を牽引する主要な要因です。座りがちな生活習慣、不健康な食生活、肥満や糖尿病の増加は、冠動脈疾患をはじめとする心疾患の世界的な急増につながっています。こうした疾患負担の増大により、迅速かつ効果的な介入への需要が高まり、ステント、カテーテル、その他の介入ツールの採用が促進されています。

2024年10月、CDC（米国疾病対策センター）は、心臓病が米国における死因の第1位であり、2023年には91万9000人以上の死因となり、全死亡者の約3分の1を占めると報告しました。心血管疾患による死亡者は34秒ごとに1人に達し、成人の約5%が冠動脈疾患を患っています。2020年から2021年にかけて、心臓病は医療費、薬剤費、生産性の低下により、4,179億ドルの経済的損失をもたらしました。

Interventional Cardiology Devices Market Summary

The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. Product innovation and integration of AI and imaging in catheter-based interventions further fuel demand. The rising prevalence of cardiovascular diseases is a primary market driver. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.

In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Interventional Cardiology Devices Market Report Scope

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. For this study, Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

• Product Outlook (Revenue, USD Million, 2021 – 2033)
• Coronary Stents

o DES

o BMS

o BRS

• PTCA Balloon Catheters
• Normal
• Specialty
• Drug-Coated
• Intravascular Imaging Catheters and Pressure Guidewires
• Accessory Devices

o PTCA Guidewires

o PTCA Guiding Catheters

o Introducer Sheaths

• Regional Outlook (Revenue, USD Million, 2021 – 2033)
• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o Italy

o Spain

o France

o Sweden

o Denmark

o Norway

• Asia Pacific

o China

o India

o Japan

o Thailand

o South Korea

o Australia

• Latin America

o Brazil

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Segment scope

1.1.2. Estimates and forecast timeline

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.7. Research Assumptions

1.8. List of Secondary Sources

1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Product outlook

2.3. Competitive Insights

Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.3. Global Interventional Cardiology Devices: Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.2. PESTLE Analysis

3.4. Technology Landscape

3.5. Case Study Analysis

Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, By Product, 2021 – 2033 (USD Million)

4.1. Definition and Scope

4.2. Product Market Share Analysis, 2024 & 2033

4.3. Segment Dashboard

4.4. Global Interventional Cardiology Devices Market, by Product, 2021 – 2033

4.5. Coronary Stents

4.5.1. Coronary stents market estimates and forecasts, 2021 – 2033 (USD Million)

4.5.2. DES

4.5.2.1. DES market estimates and forecasts, 2021 – 2033 (USD Million)

4.5.3. BMS

4.5.3.1. BMS market estimates and forecasts, 2021 – 2033 (USD Million)

4.5.4. BRS

4.5.4.1. BRS market estimates and forecasts, 2021 – 2033 (USD Million)

4.6. PTCA Balloon Catheters

4.6.1. PTCA balloon catheters market estimates and forecasts, 2021 – 2033 (USD Million)

4.6.2. Normal

4.6.2.1. Normal market estimates and forecasts, 2021 – 2033 (USD Million)

4.6.3. Specialty

4.6.3.1. Specialty market estimates and forecasts, 2021 – 2033 (USD Million)

4.6.4. Drug-Coated

4.6.4.1. Drug-coated market estimates and forecasts, 2021 – 2033 (USD Million)

4.7. Intravascular Imaging Catheters and Pressure Guidewires

4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 – 2033 (USD Million)

4.8. Accessory devices

4.8.1. Accessory devices market estimates and forecasts, 2021 – 2033 (USD Million)

4.8.2. PTCA Guidewires

4.8.2.1. PTCA guidewires market estimates and forecasts, 2021 – 2033 (USD Million)

4.8.3. PTCA Guiding Catheters

4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021 – 2033 (USD Million)

4.8.4. Introducer Sheaths

4.8.4.1. Introducer sheaths market estimates and forecasts, 2021 – 2033 (USD Million)

Chapter 5. Interventional Cardiology Devices Market Segment Analysis, By Region, 2021 – 2033 (USD Million)

5.1. Regional Market Share Analysis, 2024 & 2034

5.2. Regional Market Dashboard

5.3. Regional Market Snapshot

5.4. Interventional Cardiology Devices Market Share by Region, 2024 & 2033:

5.5. North America

5.5.1. North America Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.5.2. U.S.

5.5.2.1. Key Country Dynamics

5.5.2.2. Regulatory Scenario

5.5.2.3. Competitive Scenario

5.5.2.4. U.S. Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.5.3. Canada

5.5.3.1. Key Country Dynamics

5.5.3.2. Regulatory Scenario

5.5.3.3. Competitive Scenario

5.5.3.4. Canada Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.5.4. Mexico

5.5.4.1. Key Country Dynamics

5.5.4.2. Regulatory Scenario

5.5.4.3. Competitive Scenario

5.5.4.4. Mexico Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6. Europe

5.6.1. Europe Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.2. UK

5.6.2.1. Key Country Dynamics

5.6.2.2. Regulatory Scenario

5.6.2.3. Competitive Scenario

5.6.2.4. UK Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.3. Germany

5.6.3.1. Key Country Dynamics

5.6.3.2. Regulatory Scenario

5.6.3.3. Competitive Scenario

5.6.3.4. Germany Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.4. France

5.6.4.1. Key Country Dynamics

5.6.4.2. Regulatory Scenario

5.6.4.3. Competitive Scenario

5.6.4.4. France Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.5. Italy

5.6.5.1. Key Country Dynamics

5.6.5.2. Regulatory Scenario

5.6.5.3. Competitive Scenario

5.6.5.4. Italy Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.6. Spain

5.6.6.1. Key Country Dynamics

5.6.6.2. Regulatory Scenario

5.6.6.3. Competitive Scenario

5.6.6.4. Spain Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.7. Norway

5.6.7.1. Key Country Dynamics

5.6.7.2. Regulatory Scenario

5.6.7.3. Competitive Scenario

5.6.7.4. Norway Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.8. Sweden

5.6.8.1. Key Country Dynamics

5.6.8.2. Regulatory Scenario

5.6.8.3. Competitive Scenario

5.6.8.4. Sweden Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.6.9. Denmark

5.6.9.1. Key Country Dynamics

5.6.9.2. Regulatory Scenario

5.6.9.3. Competitive Scenario

5.6.9.4. Denmark Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7. Asia Pacific

5.7.1. Japan

5.7.1.1. Key Country Dynamics

5.7.1.2. Regulatory Scenario

5.7.1.3. Competitive Scenario

5.7.1.4. Japan Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7.2. China

5.7.2.1. Key Country Dynamics

5.7.2.2. Regulatory Scenario

5.7.2.3. Competitive Scenario

5.7.2.4. China Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7.3. India

5.7.3.1. Key Country Dynamics

5.7.3.2. Regulatory Scenario

5.7.3.3. Competitive Scenario

5.7.3.4. India Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7.4. Australia

5.7.4.1. Key Country Dynamics

5.7.4.2. Regulatory Scenario

5.7.4.3. Competitive Scenario

5.7.4.4. Australia Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7.5. South Korea

5.7.5.1. Key Country Dynamics

5.7.5.2. Regulatory Scenario

5.7.5.3. Competitive Scenario

5.7.5.4. South Korea Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.7.6. Thailand

5.7.6.1. Key Country Dynamics

5.7.6.2. Regulatory Scenario

5.7.6.3. Competitive Scenario

5.7.6.4. Thailand Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.8. Latin America

5.8.1. Brazil

5.8.1.1. Key Country Dynamics

5.8.1.2. Regulatory Scenario

5.8.1.3. Competitive Scenario

5.8.1.4. Brazil Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.8.2. Argentina

5.8.2.1. Key Country Dynamics

5.8.2.2. Regulatory Scenario

5.8.2.3. Competitive Scenario

5.8.2.4. Argentina Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.9. MEA

5.9.1. South Africa

5.9.1.1. Key Country Dynamics

5.9.1.2. Regulatory Scenario

5.9.1.3. Competitive Scenario

5.9.1.4. South Africa Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.9.2. Saudi Arabia

5.9.2.1. Key Country Dynamics

5.9.2.2. Regulatory Scenario

5.9.2.3. Competitive Scenario

5.9.2.4. Saudi Arabia Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.9.3. UAE

5.9.3.1. Key Country Dynamics

5.9.3.2. Regulatory Scenario

5.9.3.3. Competitive Scenario

5.9.3.4. UAE Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

5.9.4. Kuwait

5.9.4.1. Key Country Dynamics

5.9.4.2. Regulatory Scenario

5.9.4.3. Competitive Scenario

5.9.4.4. Kuwait Interventional Cardiology Devices Market, 2021 – 2033 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants

6.2. Company Categorization

6.3. Company Profiles

6.3.1. Abbott

6.3.1.1. Company overview

6.3.1.2. Financial performance

6.3.1.3. Product benchmarking

6.3.1.4. Strategic initiatives

6.3.2. Medtronic plc

6.3.2.1. Company overview

6.3.2.2. Financial performance

6.3.2.3. Product benchmarking

6.3.2.4. Strategic initiatives

6.3.3. Boston Scientific Corporation

6.3.3.1. Company overview

6.3.3.2. Financial performance

6.3.3.3. Product benchmarking

6.3.3.4. Strategic initiatives

6.3.4. Cardinal Health, Inc.

6.3.4.1. Company overview

6.3.4.2. Financial performance

6.3.4.3. Product benchmarking

6.3.4.4. Strategic initiatives

6.3.5. Koninklijke Philips N.V.

6.3.5.1. Company overview

6.3.5.2. Financial performance

6.3.5.3. Product benchmarking

6.3.5.4. Strategic initiatives

6.3.6. Terumo Corporation

6.3.6.1. Company overview

6.3.6.2. Financial performance

6.3.6.3. Product benchmarking

6.3.6.4. Strategic initiatives

6.3.7. Alvimedica Medical Technologies Inc.

6.3.7.1. Company overview

6.3.7.2. Financial performance

6.3.7.3. Product benchmarking

6.3.7.4. Strategic initiatives

6.3.8. Teleflex Incorporated

6.3.8.1. Company overview

6.3.8.2. Financial performance

6.3.8.3. Product benchmarking

6.3.8.4. Strategic initiatives

6.3.9. B. Braun Melsungen AG

6.3.9.1. Company overview

6.3.9.2. Financial performance

6.3.9.3. Product benchmarking

6.3.9.4. Strategic initiatives

6.3.10. Biosensors International Group, Ltd.

6.3.10.1. Company overview

6.3.10.2. Financial performance

6.3.10.3. Product benchmarking

6.3.10.4. Strategic initiatives

6.3.11. Meril Life Sciences Pvt. Ltd.

6.3.11.1. Company overview

6.3.11.2. Financial performance

6.3.11.3. Product benchmarking

6.3.11.4. Strategic initiatives

6.3.12. BIOTRONIK SE & Co. KG.

6.3.12.1. Company overview

6.3.12.2. Financial performance

6.3.12.3. Product benchmarking

6.3.12.4. Strategic initiatives

6.3.13. ACIST Medical Systems, Inc.

6.3.13.1. Company overview

6.3.13.2. Financial performance

6.3.13.3. Product benchmarking

6.3.13.4. Strategic initiatives

6.3.14. Asahi Intecc Co., Ltd.

6.3.14.1. Company overview

6.3.14.2. Financial performance

6.3.14.3. Product benchmarking

6.3.14.4. Strategic initiatives

6.3.15. Cook Medical LLC

6.3.15.1. Company overview

6.3.15.2. Financial performance

6.3.15.3. Product benchmarking

6.3.15.4. Strategic initiatives

6.3.16. Medinol Ltd.

6.3.16.1. Company overview

6.3.16.2. Financial performance

6.3.16.3. Product benchmarking

6.3.16.4. Strategic initiatives

6.3.17. Merit Medical Systems, Inc.

6.3.17.1. Company overview

6.3.17.2. Financial performance

6.3.17.3. Product benchmarking

6.3.17.4. Strategic initiatives

6.3.18. NuMED, Inc.

6.3.18.1. Company overview

6.3.18.2. Financial performance

6.3.18.3. Product benchmarking

6.3.18.4. Strategic initiatives

6.3.19. OpSens Inc.

6.3.19.1. Company overview

6.3.19.2. Financial performance

6.3.19.3. Product benchmarking

6.3.19.4. Strategic initiatives

6.3.20. Zeon Medical Inc.

6.3.20.1. Company overview

6.3.20.2. Financial performance

6.3.20.3. Product benchmarking

6.3.20.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources

Table 2 List of abbreviations

Table 3 North America Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 4 U.S. Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 5 Canada Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 6 Mexico Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 7 Europe Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 8 UK Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 9 Germany Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 10 France Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 11 Italy Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 12 Spain Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 13 Sweden Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 14 Denmark Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 15 Norway Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 16 Asia Pacific Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 17 Japan Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 18 China Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 19 India Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 20 Australia Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 21 South Korea Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 22 Thailand Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 23 Latin America Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 24 Brazil Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 25 Argentina Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 26 MEA Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 27 South Africa Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 28 Saudi Arabia Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 29 UAE Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

Table 30 Kuwait Interventional cardiology devices market, by product, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Interventional cardiology devices: market outlook

Fig. 9 Interventional cardiology devices competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook.

Fig. 12 Interventional cardiology devices driver impact

Fig. 13 Interventional cardiology devices restraint impact

Fig. 14 Interventional cardiology devices strategic initiatives analysis

Fig. 15 Interventional cardiology devices: Product movement analysis

Fig. 16 Interventional cardiology devices: Product outlook and key takeaways

Fig. 17 Coronary stents market estimates and forecasts, 2021 – 2033

Fig. 18 DES market estimates and forecasts, 2021 – 2033

Fig. 19 BMS market estimates and forecasts, 2021 – 2033

Fig. 20 BRS market estimates and forecasts, 2021 – 2033

Fig. 21 PTCA balloon catheters market estimates and forecasts, 2021 – 2033

Fig. 22 Normal market estimates and forecasts, 2021 – 2033

Fig. 23 Specialty market estimates and forecasts, 2021 – 2033

Fig. 24 Drug-coated market estimates and forecasts, 2021 – 2033

Fig. 25 Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 – 2033

Fig. 26 Accessory devices market estimates and forecasts, 2021 – 2033

Fig. 27 PTCA guidewires market estimates and forecasts, 2021 – 2033

Fig. 28 PTCA guiding catheters market estimates and forecasts, 2021 – 2033

Fig. 29 Introducer sheaths market estimates and forecasts, 2021 – 2033

Fig. 30 Global Interventional cardiology devices market: Regional movement analysis

Fig. 31 Global Interventional cardiology devices market: Regional outlook and key takeaways

Fig. 32 North America Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 33 Key country dynamics

Fig. 34 U.S. Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 35 Key country dynamics

Fig. 36 Canada Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 37 Key country dynamics

Fig. 38 Mexico Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 39 Europe Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 40 Key country dynamics

Fig. 41 UK Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 42 Key country dynamics

Fig. 43 Germany Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 44 Key country dynamics

Fig. 45 Spain Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 46 Key country dynamics

Fig. 47 France Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 48 Key country dynamics

Fig. 49 Italy Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 50 Key country dynamics

Fig. 51 Norway Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 52 Key country dynamics

Fig. 53 Denmark Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 54 Key country dynamics

Fig. 55 Sweden Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 56 Asia Pacific Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 57 Key country dynamics

Fig. 58 Japan Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 59 Key country dynamics

Fig. 60 China Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 61 Key country dynamics

Fig. 62 India Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 63 Key country dynamics

Fig. 64 Australia Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 65 Key country dynamics

Fig. 66 South Korea Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 67 Key country dynamics

Fig. 68 Thailand Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 69 Latin America Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 70 Key country dynamics

Fig. 71 Brazil Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 72 Key country dynamics

Fig. 73 Mexico Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 74 Key country dynamics

Fig. 75 Argentina Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 76 MEA Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 77 Key country dynamics

Fig. 78 South Africa Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 79 Key country dynamics

Fig. 80 Saudi Arabia Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 81 Key country dynamics

Fig. 82 UAE Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Fig. 83 Key country dynamics

Fig. 84 Kuwait Interventional cardiology devices market estimates and forecasts, 2021 – 2033 (USD Million)

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• イーサネット測定機器市場規模、成長と動向分析レポート 2025-2033年
• AIビデオ分析市場規模、成長と動向分析レポート 2025-2033年
• イベントマネジメント市場規模、成長と動向分析レポート 2025-2033年
• IPTVソフトウェア市場規模、成長と動向分析レポート 2025-2033年
• スマートホームセキュリティカメラ市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧